ARYYX
Price
$14.58
Change
+$0.02 (+0.14%)
Updated
Jun 5 closing price
Net Assets
798.7M
CSSPX
Price
$58.54
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Net Assets
2.31B
Interact to see
Advertisement

ARYYX vs CSSPX

Header iconARYYX vs CSSPX Comparison
Open Charts ARYYX vs CSSPXBanner chart's image
ARYYX vs CSSPX Comparison Chart in %
View a ticker or compare two or three
VS
ARYYX vs. CSSPX commentary
Jun 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARYYX is a Buy and CSSPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSSPX has more cash in the bank: 2.32B vs. ARYYX (799M). CSSPX (3.19) and ARYYX (3.10) have matching dividends . ARYYX was incepted earlier than CSSPX: ARYYX (9 years) vs CSSPX (29 years). CSSPX (0.93) is less costly to investors than ARYYX (0.76). ARYYX is a more actively managed with annual turnover of: 137.00 vs. CSSPX (57.00). ARYYX has a lower initial minimum investment than CSSPX: ARYYX (0) vs CSSPX (100000). ARYYX annual gain was more profitable for investors over the last year : 13.69 vs. CSSPX (11.72). ARYYX return over 5 years is better than : 10.83 vs. CSSPX (7.20).
ARYYXCSSPXARYYX / CSSPX
Total Expense Ratio0.760.9084%
Annual Report Gross Expense Ratio0.760.9382%
Fund Existence9 years29 years-
Gain YTD8.7387.334119%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets799M2.32B35%
Annual Yield % from dividends3.103.1997%
Returns for 1 year13.6911.72117%
Returns for 3 years38.4228.88133%
Returns for 5 years10.837.20150%
Returns for 10 yearsN/A52.88-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ODINX107.36N/A
N/A
Invesco Discovery R
AIEMX16.49N/A
N/A
Alger Emerging Markets I
HGHCX25.05N/A
N/A
Hartford Healthcare C
JMVCX16.43N/A
N/A
Janus Henderson Mid Cap Value C
DFDMX33.07-0.37
-1.11%
DF Dent Midcap Growth Investor